Comprehensive kits for simultaneous detection of multiple tumor-associated markers using IHC, PCR, or FISH methodologies. These panels enable comprehensive tumor characterization and subtyping.
Manufactured by
China
Guangzhou LBP Medicine Science & Technology Co., Ltd, founded in 2005, is the first publicly listed company in China's pathological diagnosis sector (listed on SSE STAR Market in 2020). The company specializes in R&D and manufacturing of pathological diagnostic products, with core technologies including liquid-based cytology, PCR, FISH probe labeling, and IHC antibody screening. LBP holds 60+ patents including 15 invention patents, with 500+ registered products serving nearly 1,800 medical institutions nationwide. Products are CE certified and approved by BSI and Japan MHLW.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shandong Kanghua Biotechnology Co.,Ltd.
China · 2 relevant products
Nantong Egens Biotechnology Co., Ltd.
China · 1 relevant product
Xiamen Boson Biotech Co., Ltd
China · 1 relevant product
75 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 110 closest product alternatives
Shandong Kanghua Biotechnology Co.,Ltd. · China
Diagnostic kits for detection and quantification of tumor-associated markers for oncology applications. Supports cancer screening, diagnosis, and treatment monitoring in clinical practice.
Nantong Egens Biotechnology Co., Ltd. · China
In vitro diagnostic kits for detection and quantification of cancer biomarkers in patient samples. Available in multiple formats including ELISA and CLIA for oncology applications.
Xiamen Boson Biotech Co., Ltd · China
Immunoassay test kits for detection of various tumor-associated biomarkers in serum and plasma samples. Utilized for cancer screening, diagnosis, and monitoring in oncology.
107 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products